Omada Health正式发布Glp-1 Flex Care创新方案，为企业客户开辟了一条可定制化的肥胖管理支持通道。该计划通过模块化服务设计，允许雇主根据员工需求动态调整GLP-1受体激动剂等前沿疗法的覆盖范围，既控制医疗成本又提升干预效果。
不同于传统固定套餐模式，Flex Care采用阶梯式服务框架，企业可自主选择基础健康指导、数字疗法平台接入或药物联合治疗等不同层级。这种弹性化方案特别适合正在评估GLP-1类药物临床应用价值的中小型企业，既能规避长期用药的财务风险，又能通过Omada的临床数据平台实时追踪代谢指标改善情况。
值得注意的是，该计划整合了Omada深耕十年的慢性病管理经验，将行为科学干预与药物疗法深度融合。通过智能设备数据同步和临床教练远程指导，系统可动态优化个体化治疗方案，在保障用药安全的同时显著提升体重管理依从性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.